Our low-cost & AI-powered liquid biopsy tests are designed for early disease detection and patient stratification. By leveraging advanced machine learning and low-coverage genomic sequencing, we deliver fast, accurate, and affordable results.
With one unified test, we provide insights into cancer, chronic illness, or viral infection.
Our science is built on cutting-edge research in the field of DNA Damage Repair. By monitoring the body's own defense mechanisms, we can detect and track the progression of cancer and other diseases.
We couple advanced machine learning models of each repair pathway's unique somatic mutation signature with the world's most comprehensive somatic mutation callers.
Interested in learning more or partnering with us? Reach out to our team and we'll get back to you as soon as possible.
Email Us© 2025 NeoplasmAI. All rights reserved.